Developmental Research Program
发展研究计划
基本信息
- 批准号:10248319
- 负责人:
- 金额:$ 7.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-24 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdvertisementsAfrican AmericanAttentionAwardBasic ScienceBrainBrain NeoplasmsChargeClinicalClinical ResearchClinical SciencesClinical and Translational Science AwardsCollaborationsCommunitiesDevelopmentDiagnosisEnsureEvolutionFacultyFeedbackFosteringFundingFunding MechanismsGoalsGrantIndividualInfrastructureInstitutesInstitutionJournalsLaboratoriesLeadershipMalignant NeoplasmsMalignant neoplasm of brainMedicalMedicineMinorityMinority RecruitmentPatient-Focused OutcomesPatientsPeer ReviewPreventionPrimary Brain NeoplasmsProbabilityProcessProgress ReportsResearchResearch PersonnelResearch Project GrantsResourcesScientistSourceTeacher Professional DevelopmentTestingTranslatingTranslational ResearchTumor BiologyUnited States National Institutes of HealthUniversitiesUpdateWomanWorkbench to bedsideexperienceimprovedimproved outcomeinnovationinterestmedical schoolsmeetingsmemberneuro-oncologynovelnovel strategiesprofessorprogramsrecruitsuccesswomen faculty
项目摘要
ABSTRACT – Developmental Research Program
The Developmental Research Program (DRP) is a critical component of the Duke SPORE in Brain Cancer,
supporting (1) pilot research projects with translational potential relevant to brain tumors and (2) the
participation of experienced investigators from other fields to work in brain tumor research. Projects are
encouraged to test novel concepts and paradigms that bring new approaches into the field to advance
understanding of brain tumor biology and improve brain tumor diagnosis, treatment, and/or prevention. The
DRP will support two to three promising projects each year, with the option of renewed funding for one
additional year with excellent progress. Projects that have a strong likelihood of either developing into full
SPORE projects or projects that can receive funding as independent research projects (e.g., R01s) will be
specifically targeted for support. Both individual investigator and collaborative research are eligible. The
Specific Aims of this DRP are: 1) To identify and support meritorious basic, translational or clinical research
projects that have a high probability of impacting the diagnosis, treatment or prevention of brain tumors; 2) To
attract new, outstanding and experienced investigators, currently not working on brain tumors, to pursue brain
tumor research; 3) To facilitate collaborative research to test novel concepts and paradigms relevant to brain
tumor biology, diagnosis, treatment or prevention, and 4) To evaluate progress on funded projects and
facilitate their evolution into full SPORE projects or into independently funded projects. Through these Aims,
the DRP helps to ensure success in the Duke Brain SPORE's charge to translate research findings from the
bench to the bedside of brain tumor patients.
摘要 - 发展研究计划
发展研究计划(DRP)是杜克孢子中脑癌的关键组成部分,
支持(1)试点研究项目,具有与脑肿瘤相关的潜在潜力和(2)
来自其他领域的经验丰富的研究人员参与脑肿瘤研究。项目是
鼓励测试新的概念和范式,这些概念和范式将新方法带入现场
了解脑肿瘤生物学并改善脑肿瘤诊断,治疗和/或预防。这
DRP每年将支持两到三个有前途的项目,并可以选择重新资金
额外的一年,进步良好。具有很有可能成熟的可能性的项目
作为独立研究项目(例如R01)的孢子项目或可以收到资金的项目将是
专门针对支持。个人调查员和协作研究都有资格。这
该DRP的具体目的是:1)识别和支持有功的基础,翻译或临床研究
影响诊断,治疗或预防脑肿瘤的可能性很高; 2)到
吸引新的,杰出的和经验丰富的研究人员,目前尚未从事脑肿瘤,以追求大脑
肿瘤研究; 3)促进协作研究以测试与大脑相关的新颖概念和范式
肿瘤生物学,诊断,治疗或预防,以及4)评估资助项目的进度和
促进他们发展到全孢子项目或独立资助的项目中。通过这些目标,
DRP有助于确保Duke Brain Spore收费的成功,从
长凳到脑肿瘤患者的床边。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN H. SAMPSON其他文献
JOHN H. SAMPSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN H. SAMPSON', 18)}}的其他基金
Project 1: Targeting cytomegalovirus antigens in glioblastoma with regulatory T cell depletion
项目 1:通过消除调节性 T 细胞来靶向胶质母细胞瘤中的巨细胞病毒抗原
- 批准号:
10006177 - 财政年份:2018
- 资助金额:
$ 7.54万 - 项目类别:
Clinical Brain Tumor Development of a Cytomegalovirus-targeted Therapeutic with Vaccine pre-conditioning to Validate Novel Predictors of Vaccine Efficacy
通过疫苗预处理进行巨细胞病毒靶向治疗的临床脑肿瘤开发,以验证疫苗功效的新预测因子
- 批准号:
10310436 - 财政年份:2018
- 资助金额:
$ 7.54万 - 项目类别:
Project 1: Targeting cytomegalovirus antigens in glioblastoma with regulatory T cell depletion
项目 1:通过消除调节性 T 细胞来靶向胶质母细胞瘤中的巨细胞病毒抗原
- 批准号:
10246884 - 财政年份:2018
- 资助金额:
$ 7.54万 - 项目类别:
CCL3 as a Developmental Therapeutic to Enhance Brain Tumor Therapy
CCL3 作为一种增强脑肿瘤治疗的发育疗法
- 批准号:
9216208 - 财政年份:2016
- 资助金额:
$ 7.54万 - 项目类别:
CCL3 as a Developmental Therapeutic to Enhance Brain Tumor Therapy
CCL3 作为一种增强脑肿瘤治疗的发育疗法
- 批准号:
10055778 - 财政年份:2016
- 资助金额:
$ 7.54万 - 项目类别:
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
人 EGFRvIII 特异性 BiTE 用于治疗胶质母细胞瘤
- 批准号:
9750830 - 财政年份:2015
- 资助金额:
$ 7.54万 - 项目类别:
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
人 EGFRvIII 特异性 BiTE 用于治疗胶质母细胞瘤
- 批准号:
9095464 - 财政年份:2015
- 资助金额:
$ 7.54万 - 项目类别:
相似海外基金
The SRBR 2022 Meeting: Rhythms of Life - from Molecules to Policy
SRBR 2022 会议:生命的节奏 - 从分子到政策
- 批准号:
10467738 - 财政年份:2022
- 资助金额:
$ 7.54万 - 项目类别:
Understanding Tobacco Treatment Refusal Among African-Americans in the Context of Lung Cancer Screening
了解肺癌筛查背景下非裔美国人拒绝烟草治疗的情况
- 批准号:
9905136 - 财政年份:2016
- 资助金额:
$ 7.54万 - 项目类别:
The Effect of Food Marketing and Attentional Biases on Eating behaviors in the African American Adolescent Girls
食品营销和注意力偏差对非裔美国少女饮食行为的影响
- 批准号:
9126868 - 财政年份:2016
- 资助金额:
$ 7.54万 - 项目类别: